FrancophonIA/ELRC3.0 huggingface dataset:
English: Other medicines and Emgality
Slovenian: Druga zdravila in zdravilo Emgality
English: What Emgality looks like and contents of the pack
Slovenian: Izgled zdravila Emgality in vsebina pakiranja
English: Galcanezumab is a humanised IgG4 monoclonal antibody that binds calcitonin gene-related peptide (CGRP) thus preventing its biological activity.
Slovenian: Galkanezumab je humanizirano monoklonsko protitelo IgG4, ki se veže na peptid, povezan z genom za kalcitonin (CGRP - calcitonin gene-related peptide), s čimer preprečuje njegovo biološko aktivnost.
English: It is unknown whether galcanezumab is excreted in human milk.
Slovenian: Ni znano, ali se galkanezumab izloča v materino mleko.
English: Emgality is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
Slovenian: Zdravilo Emgality je indicirano za profilakso migrene pri odraslih, ki imajo vsaj 4 migrenske dni na mesec.
English: N = number of patients; CI95 % = 95 % confidence interval.
Slovenian: >0,05e n = število bolnikov; IZ95 % = 95-odstotni interval zaupanja aIzide učinkovitosti so vrednotili v času med 1. in 3. mesecem.
English: • the medicine is cloudy, is discolored, or has small particles
Slovenian: • je zdravilo motno, spremeni barvo ali vsebuje majhne delce;
English: • Your doctor, pharmacist or nurse can help you decide where on your body to inject your dose.
Slovenian: • Zdravnik, farmacevt ali medicinska sestra vam lahko pomaga pri odločitvi, na katero mesto na vašem telesu si boste injicirali svoj odmerek.
English: • Do not put the base cap back on - this could damage the needle.
Slovenian: • Pokrovčka podnožja ne nameščajte ponovno nazaj, saj bi s tem lahko poškodovali iglo.
English: • When you are ready to inject, pull the needle cap off and throw it away in the bin.
Slovenian: • Ko ste pripravljeni za injiciranje, odvijte pokrovček podnožja in ga vrzite v koš za smeti.
English: Fertility studies in animals do not indicate harmful effects with respect to male and female fertility (see section 5.3).
Slovenian: Študije na živalih ne kažejo škodljivih učinkov na plodnost pri moških in ženskah (glejte poglavje 5.3).
English: As a precautionary measure, it is preferable to avoid the use of galcanezumab during pregnancy.
Slovenian: Iz previdnosti se je med nosečnostjo bolje izogibati uporabi galkanezumaba.
English: 2 Place and Unlock
Slovenian: 2 Namestite in odklenite
English: Injection site location (abdomen, thigh, buttocks and arm) did not significantly influence the absorption of galcanezumab.
Slovenian: Mesto injiciranja (trebuh, stegno, zadnjica in roka) ni bistveno vplivalo na absorpcijo galkanezumaba.
English: Based on a population PK analysis, bilirubin concentration or Cockcroft-Gault creatinine clearance (range: 24 to 308 mL/min) did not significantly influence the apparent clearance of galcanezumab.
Slovenian: Na podlagi populacijske farmakokinetične analize koncentracija bilirubina ali očistek kreatinina po CockcroftGaultovi formuli (razpon od 24 do 308 ml/min) nista bistveno vplivala na navidezni očistek galkanezumaba.
English: The baseline scores of the MIDAS reflected severe migraine related disability of patients in EVOLVE-1 and EVOLVE-2 (mean of 33.1) and a very severely disabled population (mean of 67.2) in REGAIN.
Slovenian: Izhodiščni rezultati vprašalnika MIDAS so pokazali močno z migreno povezano zmanjšano opravilno sposobnost pri bolnikih v študijah EVOLVE-1 in EVOLVE-2 (povprečje 33,1) ter zelo močno zmanjšano opravilno sposobnost populacije (povprečje 67,2) v študiji REGAIN.
English: How can I tell if my injection is complete?
Slovenian: Kako ugotovim, ali je injiciranje končano?
English: In all 3 studies, the overall mean change from baseline in number of monthly Migraine Headache Days (MHDs) was the primary efficacy measure.
Slovenian: V vseh treh študijah je bilo primarno merilo učinkovitosti celokupna povprečna sprememba v številu dni migrenskega glavobola (MHD - Migraine Headache Days) na mesec od izhodišča.
English: • Remove the needle from your skin
Slovenian: • Odstranite iglo s kože.
English: Your doctor, pharmacist or nurse can help you choose the injection site that is best for you.
Slovenian: Zdravnik, farmacevt ali medicinska sestra vam lahko pomaga izbrati mesto injiciranja, ki je najbolj ustrezno za vas.
English: After You Inject Your Medicine
Slovenian: Po injiciranju zdravila
English: Human immunoglobulin (IgG) is known to cross the placental barrier.
Slovenian: Znano je, da humani imunoglobulin (IgG) prehaja skozi placento.
English: You and your doctor or nurse should decide if you can inject Emgality yourself.
Slovenian: Skupaj z zdravnikom ali medicinsko sestro se boste odločili, ali si lahko zdravilo Emgality injicirate sami.
English: • If you have vision or hearing problems, do not use the pen without help from a caregiver.
Slovenian: • Če imate težave z vidom ali sluhom, ne uporabljajte injekcijskega peresnika brez pomoči negovalca.
English: • Remove the needle from your skin and gently let go of your skin.
Slovenian: • Iglo izvlecite iz kože in kožo nežno spustite.
English: For the MIDAS, higher scores indicate more disability.
Slovenian: Pri vprašalniku MIDAS višji rezultat pomeni bolj zmanjšano opravilno sposobnost.
English: N = 208 N = 425 N = 226
Slovenian: 120 mg 240 mg n = 210 n = 208 n = 425 n=226 n=220 n=450
English: Serious hypersensitivity reactions including cases of anaphylaxis, angioedema and urticaria have been reported.
Slovenian: Poročali so resnih preobčutljivostnih reakcijah, vključno s primeri anafilaksije, angioedema in urtikarije.
English: • Clean and dry the injection site before you inject.
Slovenian: • Pred injiciranjem očistite in osušite injekcijsko mesto.
English: Figure 2 Reduction in monthly migraine headache days over time in study REGAIN
Slovenian: Zmanjšanje števila dni z migrenskim glavobolom na mesec v časovnem intervalu v študiji REGAIN
English: In pooled data from studies EVOLVE-1 and EVOLVE-2, more than 19 % of the patients treated with galcanezumab maintained a ≥ 50 % response from Month 1 to Month 6 versus 8 % of the patients on placebo (p < 0.001).
Slovenian: V združenih podatkih iz študij EVOLVE-1 in EVOLVE-2 je več kot 19 % bolnikov, zdravljenih z galkanezumabom, ohranilo ≥ 50odstotni odziv med 1. in 6. mesecem, v primerjavi z 8 % bolnikov, ki so prejemali placebo (p < 0,001).
English: Studies EVOLVE-1 and EVOLVE-2 had a 6 month, double-blind, placebo-controlled treatment period.
Slovenian: Študiji EVOLVE-1 in EVOLVE-2 sta imeli 6-mesečno, dvojno slepo, s placebom nadzorovano obdobje zdravljenja.
English: Emgality is given by injection under your skin (subcutaneous injection).
Slovenian: Zdravilo Emgality se daje z injekcijo pod kožo (subkutano injekcijo).
English: Monthly doses of 120 mg or 240 mg achieved a steady-state Cmax (Cmax, ss) of approximately 28 μg/mL (35 % CV) or 54 μg/mL (31 % CV), respectively.
Slovenian: Po mesečnih odmerkih 120 mg oziroma 240 mg je bila koncentracija Cmax v stanju dinamičnega ravnovesja (Cmax, ss) približno 28 μg/ml (35 % KV) oziroma 54 μg/ml (31 % KV).
English: Put the original package with any unused syringes back in the refrigerator.
Slovenian: Originalno pakiranje z nerabljenimi injekcijskimi brizgami vrnite v hladilnik.
English: The active substance is galcanezumab.
Slovenian: Učinkovina je galkanezumab.
English: Over 72 % of patients completing the study reported a 50 % reduction in MHDs at month 12.
Slovenian: 12. mesecu poročalo o 50-odstotnem zmanjšanju števila MHD.
English: Based on a population pharmacokinetic (PK) analysis, following a loading dose of 240 mg the maximum serum concentration (Cmax) of galcanezumab was approximately 30 μg/mL (27 % coefficient of variation, (CV)) and the time to Cmax was 5 days postdose.
Slovenian: Na podlagi populacijske farmakokinetične analize je bila po polnilnem odmerku 240 mg najvišja koncentracija galkanezumaba v serumu (Cmax) približno 30 μg/ml (27 % koeficient variacije (KV)), čas do Cmax pa je bil 5 dni po odmerku.
English: Before using your pre-filled syringe:
Slovenian: Pred uporabo napolnjene injekcijske brizge:
English: Do not take a double dose to make up for forgotten injection If you have forgotten to inject a dose of Emgality, inject the missed dose as soon as possible and then inject the next dose after a month from that date.
Slovenian: Če ste si pozabili injicirati odmerek zdravila Emgality, si pozabljeni odmerek injicirajte takoj, kot je mogoče, nato pa si naslednji odmerek injicirajte en mesec od tega datuma.
English: No dose adjustment is required in patients with mild to moderate renal impairment or hepatic impairment (see section 5.2).
Slovenian: Pri bolnikih z blago ali zmerno ledvično okvaro ali jetrno okvaro prilagajanje odmerka ni potrebno (glejte poglavje 5.2).
English: - After the first dose, you will use one syringe (120 mg) every month.
Slovenian: - Po prvem odmerku boste vsak mesec uporabili eno injekcijsko brizgo (120 mg).
English: It may be colourless to slightly yellow.
Slovenian: Raztopina je lahko brezbarvna do rahlo rumena.
English: Emgality should not be used if the solution is cloudy, discoloured or contains particles, or if any part of the device appears to be damaged.
Slovenian: Zdravila Emgality ne smete uporabiti, če je raztopina motna, obarvana ali vsebuje delce ali če je kateri koli del pripomočka videti poškodovan.
English: Do not rub the injection site.
Slovenian: Injekcijskega mesta ne drgnite.
English: Based on a population PK analysis, the apparent volume of distribution of galcanezumab was 7.3 L. Biotransformation
Slovenian: Na podlagi populacijske farmakokinetične analize je bil navidezni volumen porazdelitve galkanezumaba 7,3 l. Biotransformacija
English: Galcanezumab is to be injected subcutaneously in the abdomen, thigh, back of the upper arm, or in the gluteal region.
Slovenian: Galkanezumab je treba injicirati subkutano v trebuh, stegno, hrbtni del nadlakti ali v glutealni predel.
English: Lock/Unlock Symbols
Slovenian: Simbola za zaklepanje/ odklepanje
English: As a humanised IgG4 monoclonal antibody, galcanezumab is expected to be degraded into small peptides and amino acids via catabolic pathways in the same manner as endogenous IgG.
Slovenian: Ker je galkanezumab humanizirano monoklonsko protitelo IgG4, je pričakovati, da se bo po katabolnih poteh enako kot endogeni IgG razgradil v majhne peptide in aminokisline.
English: If you forget to use Emgality
Slovenian: Če ste pozabili uporabiti zdravilo Emgality
English: Q. What if the needle did not retract after my injection?
Slovenian: V. Kaj naj storim, če se igla po injiciranju ne umakne?
English: If these conditions are exceeded, the pre-filled syringe must be discarded.
Slovenian: Če te pogoje presežete, morate napolnjeno injekcijsko brizgo zavreči.
English: How to store Emgality 6.
Slovenian: Shranjevanje zdravila Emgality 6.
English: Completion rate of the double-blind treatment phase for patients who received galcanezumab ranged from 82.8 % to 87.7 %.
Slovenian: Dvojno slepo fazo zdravljenja je zaključilo od 82,8 % do 87,7 % bolnikov, ki so prejemali galkanezumab.
English: Make sure a sharps disposal container is close by.
Slovenian: Prepričajte se, da imate vsebnik za ostre odpadke v bližini.
English: What if I see air bubbles in my Emgality syringe?
Slovenian: Kaj moram narediti, če v svoji injekcijski brizgi Emgality opazim zračne mehurčke?
English: Episodic migraine
Slovenian: Epizodna migrena
English: Q. How can I tell if my injection is complete?
Slovenian: V. Kako ugotovim, ali je injiciranje končano?
English: • Each syringe is for ONE-TIME USE ONLY.
Slovenian: • Vsaka injekcijska brizga je namenjena LE ZA ENKRATNO UPORABO.
English: The cumulative review of the data, taking into account pharmacological plausibility, temporal association to treatment and a general lack of confounding factors, concluded that anaphylaxis, angioedema, and rash should be added as new adverse drug reactions in the SmPC and package leaflet of galcanezumab.
Slovenian: Z upoštevanjem farmakološke verjetnosti, časovne povezave z zdravljenjem in splošne odsotnosti drugih možnih vzročnih dejavnikov je bil po kumulativnem pregledu podatkov sprejet zaključek, da je treba anafilaksijo, angioedem in izpuščaj dodati v povzetek glavnih značilnosti zdravila in navodilo za uporabo galkanezumaba kot nove neželene učinke.
English: Make sure the pen is locked.
Slovenian: Prepričajte se, da je injekcijski peresnik zaklenjen.
English: Patients received placebo, galcanezumab 120 mg/month (with an initial loading dose of 240 mg for the first month) or galcanezumab 240 mg/month and were allowed to use medication for the acute treatment of migraine.
Slovenian: Bolniki so prejemali placebo, 120 mg galkanezumaba/mesec (z začetnim polnilnim odmerkom 240 mg v prvem mesecu) ali 240 mg galkanezumaba/mesec in so smeli uporabljati zdravila za akutno zdravljenje migrene.
English: The overall mean reduction from baseline in the number of monthly MHDs averaged over the treatment phase was 5.6 days for the 120 mg dose group and 6.5 days for the 240 mg dose group.
Slovenian: Celokupno povprečno zmanjšanje mesečnega števila MHD, s povprečno vrednostjo za fazo zdravljenja, od izhodišča je bilo 5,6 dneva v skupini, ki je prejemala 120 g odmerek, in 6,5 dneva v skupini, ki je prejemala 240 mg odmerek.
English: Read the full Package Leaflet for Emgality inside this box to learn more about your medicine.
Slovenian: Preberite celotno navodilo za uporabo zdravila Emgality, priloženo v škatli, kjer boste izvedeli več o zdravilu.
English: Completion rate of the double-blind treatment phase for patients who received galcanezumab was 95.3 %.
Slovenian: Dvojno slepo fazo zdravljenja je zaključilo 95,3 % bolnikov, ki so prejemali galkanezumab.
English: - The first time you receive Emgality your doctor or nurse will inject two syringes (total 240 mg).
Slovenian: - Prvič, ko boste prejeli zdravilo Emgality, vam bo zdravnik ali medicinska sestra injiciral/-a vsebino dveh injekcijskih brizg (skupaj 240 mg).
English: 100 % Responders Percentage, % P-value
Slovenian: 100-odstotni odziv odstotek, % p-vrednost
English: If you stop using Emgality
Slovenian: Če ste prenehali uporabljati zdravilo Emgality
English: Specific clinical pharmacology studies to evaluate the effects of renal impairment and hepatic impairment on the PK of galcanezumab have not been conducted.
Slovenian: Posebnih kliničnih farmakoloških študij za ovrednotenje učinkov okvare ledvic in jeter na farmakokinetiko galkanezumaba niso izvedli.
English: Annex IV Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Slovenian: Znanstveni zaključki in podlaga za spremembo pogojev dovoljenja (dovoljenj) za promet z zdravilom
English: Do not microwave the syringe, run hot water over it, or leave it in direct sunlight.
Slovenian: Injekcijske brizge ne grejte v mikrovalovni pečici, ne oblivajte je z vročo vodo in ne puščajte je na neposredni sončni svetlobi.
English: Bottom/ Needle end
Slovenian: Dno/Konec igle
English: • If you have vision problems, do not use Emgality syringe without help from a caregiver.
Slovenian: • Če imate težave z vidom ali sluhom, ne uporabljajte injekcijske brizge Emgality brez pomoči negovalca.
English: Papendorpseweg 83, 3528 BJ Utrecht The Netherlands
Slovenian: Papendorpseweg 83, 3528 BJ Utrecht
English: 240 mg
Slovenian: 120 mg 240 mg
English: Renal elimination of IgG monoclonal antibody is low.
Slovenian: Izločanje monoklonskega protitelesa IgG prek ledvic je majhno.
English: The other ingredients are: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sodium chloride and water for injections.
Slovenian: Druge sestavine zdravila so: L-histidin, L-histidinijev klorid monohidrat, polisorbat 80, natrijev klorid in voda za injekcije.
English: Take the syringe from the refrigerator
Slovenian: Vzemite injekcijsko brizgo iz hladilnika
English: This medicine contains less than 1 mmol sodium (23 mg) per 120 mg dose, that is to say it is essentially “sodium-free”.
Slovenian: To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 120 mg odmerek, kar v bistvu pomeni "brez natrija".
English: ImClone Systems LLC 33 ImClone Drive Branchburg New Jersey NJ 08876
Slovenian: ImClone Systems LLC 33 ImClone Dr., Branchburg
English: At Gestational Day 29, in rabbit embryo-foetal development toxicity study skull anomaly was found in one male foetus from mother treated with galcanezumab at an exposure approximately 33 times the human exposure at 240 mg.
Slovenian: V študiji toksičnosti za embriofetalni razvoj kuncev so 29. dan gestacije opazili anomalije lobanje pri enem moškem plodu pri materi, zdravljenimi z galkanezumabom pri izpostavljenosti, približno 33-krat večji od izpostavljenosti pri človeku pri 240 mg odmerku.
English: What if there is a drop of liquid on the tip of the needle when I remove the needle cap?
Slovenian: Kaj če opazim kapljico tekočine na konici igle, ko odstranim pokrovček igle?
English: Before you use the EMGALITY syringe, read and carefully follow all the step-by-step instructions.
Slovenian: Pred uporabo injekcijske brizge EMGALITY preberite in skrbno upoštevajte vsa navodila po korakih.
English: Its colour may vary from colourless to slightly yellow.
Slovenian: Barva raztopine je lahko brezbarvna do rahlo rumena.
English: Name and address of the manufacturer(s) of the biological active substance(s)
Slovenian: ZA SPROŠČANJE SERIJ Ime in naslov izdelovalca (izdelovalcev) biološke učinkovine (učinkovin)
English: The instructions for using the syringe included with the Package Leaflet, must be followed carefully.
Slovenian: Navodila za uporabo injekcijske brizge, ki so priložena navodilu za uporabo zdravila, je treba natančno upoštevati.
English: While urticaria is uncommon, serious cases of urticaria have been reported in galcanezumab clinical studies.
Slovenian: Urtikarija se sicer pojavlja občasno, vendar so v kliničnih študijah z galkanezumabom poročali o resnih primerih urtikarije.
English: The galcanezumab Cmax, ss at monthly doses of 120 mg is achieved after the 240 mg loading dose.
Slovenian: Vrednost Cmax,ss galkanezumaba pri mesečnih odmerkih 120 mg je dosežena po polnilnem odmerku 240 mg.
English: • the expiration date printed on the label has passed
Slovenian: • je datum izteka roka uporabnosti, natisnjen na nalepki,
English: Emgality pre-filled syringe is for single use only and contains one dose of Emgality (120 mg).
Slovenian: Napolnjena injekcijska brizga zdravila Emgality je samo za enkratno uporabo in vsebuje en odmerek zdravila Emgality (120 mg).
English: The 120 mg dose was associated with a statistically significant reduction in disability over placebo.
Slovenian: 120 mg odmerek je bil povezan s statistično pomembnim izboljšanjem zmanjšane opravilne sposobnosti v primerjavi s placebom.
English: Galcanezumab has not been studied in elderly patients.
Slovenian: Pri starejših bolnikih galkanezumaba niso preučevali.
English: 4.4 Special warnings and precautions for use
Slovenian: 4.4 Posebna opozorila in previdnostni ukrepi Sledljivost
English: Chronic Migraine
Slovenian: Kronična migrena
English: Uncommon side effects (may affect up to 1 in 100 people): - Hives (raised itchy areas of skin)
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov): - koprivnica (dvignjeni, srbeči predeli kože)
English: Talk to your doctor, pharmacist or nurse before or during treatment with Emgality if: - you have a serious cardiovascular disease.
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom uporabe in med uporabo zdravila Emgality se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, če: - imate resno srčno-žilno bolezen.
English: Eli Lilly Nederland B. V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Slovenian: Eli Lilly Nederland B. V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska.
English: seconds
Slovenian: sekund
English: • Keep holding the clear base firmly against your skin.
Slovenian: • Prozorno podnožje še naprej trdno držite na koži.
English: Excipients: L-histidine, L-histidine hydrochloride monohydrate, sodium chloride, polysorbate 80, water for injections.
Slovenian: Pomožne snovi: L-histidin, L-histidinijev klorid monohidrat, natrijev klorid, polisorbat 80, voda za injekcije.
English: 4.7 Effects on ability to drive and use machines
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev.
English: No dose adjustment is required as the pharmacokinetics of galcanezumab are not affected by age.
Slovenian: Prilagajanje odmerka ni potrebno, saj starost ne vpliva na farmakokinetiko galkanezumaba.
English: A signal for hypersensitivity reactions, based on cases reported from post-marketing spontaneous data sources was reviewed by the MAH in the PSUR.
Slovenian: Imetnik dovoljenja za promet z zdravilom je v poročilu PSUR na podlagi primerov, o katerih so spontano poročali v obdobju po uvedbi zdravila na trg, pregledal signal za preobčutljivostne reakcije.
English: If the syringe is stored at a higher temperature or for a longer period it must be discarded.
Slovenian: Če injekcijsko brizgo hranite dlje časa ali jo hranite pri višji temperaturi, jo morate zavreči.
English: MHD with Acute Medication Use Baseline Mean Change Treatment Difference
Slovenian: Število MHD in akutno uporabo zdravil izhodišče povprečna sprememba razlika med zdravljenjema
English: The recommended dose is 120 mg galcanezumab injected subcutaneously once monthly, with a 240 mg loading dose as the initial dose.
Slovenian: Priporočeni odmerek je 120 mg galkanezumaba, ki se injicira subkutano enkrat mesečno, z začetnim polnilnim odmerkom 240 mg.
English: • The grey syringe plunger should be pushed all the way to end of the syringe.
Slovenian: • Sivi bat brizge morate potisniti do konca brizge.
English: The pre-filled syringe should be inspected visually prior to administration.
Slovenian: Napolnjeno injekcijsko brizgo morate pred uporabo vizualno pregledati.
English: eNot adjusted for multiple comparisons.
Slovenian: eNi prilagojeno po metodi večkratnih primerjav.
English: The effect of galcanezumab on human fertility has not been evaluated.
Slovenian: Plodnost Učinka galkanezumaba na plodnost pri ljudeh niso ocenili.
English: Sixty-four percent of the patients had acute headache medication overuse at baseline.
Slovenian: 64 % bolnikov je ob izhodišču čezmerno uporabljalo zdravila za akutni glavobol.
English: Taking into account the PRAC Assessment Report on the PSUR(s) for galcanezumab, the scientific conclusions of CHMP are as follows:
Slovenian: Upoštevajoč poročilo Odbora za oceno tveganja na področju farmakovigilance (PRAC) o oceni rednih posodobljenih poročil o varnosti zdravila (PSUR) za galkanezumab je Odbor za zdravila za uporabo v humani medicini (CHMP) sprejel naslednje znanstvene zaključke:
English: Galcanezumab was associated with a statistically significant reduction in disability over placebo.
Slovenian: Galkanezumab je bil povezan s statistično pomembnim izboljšanjem zmanjšane opravilne sposobnosti v primerjavi s placebom.
English: A caregiver may also give you your Emgality injection after proper training.
Slovenian: Po ustreznem usposabljanju vam injekcijo zdravila Emgality lahko daje tudi negovalec.
English: • Your doctor or nurse should show you how to prepare and inject Emgality using the syringe.
Slovenian: • Zdravnik ali medicinska sestra vam bo pokazal/-a, kako pripraviti in injicirati zdravilo Emgality z injekcijsko brizgo.
English: How to use Emgality
Slovenian: Kako uporabljati zdravilo Emgality
English: Emgality pre-filled pen is for single use only and contains one dose of Emgality (120 mg).
Slovenian: Napolnjeni injekcijski peresnik zdravila Emgality je samo za enkratno uporabo in vsebuje en odmerek zdravila Emgality (120 mg).
English: That is the normal operation of the pen.
Slovenian: To je normalno delovanje injekcijskega peresnika.
English: REGAIN - Chronic Migraine Emgality
Slovenian: REGAIN - kronična migrena